Brad Bowers

kinda wanted to get an update on market situation, you know, market share dynamics with the competing product launch

just how you we should think through that. Thank you.

I think there's a little bit of the elephant in the room on what the agreement looks like for 2027 and beyond.

I just wanted to think about the impact of Tempus as therapy selection gets more widely formally included into labels

I just wanted to kind of hear about what the expectation should be for gross margin.